Edition:
United Kingdom

Aimmune Therapeutics Inc (AIMT.OQ)

AIMT.OQ on NASDAQ Stock Exchange Global Select Market

19.36USD
23 Aug 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$19.36
Open
$20.30
Day's High
$20.34
Day's Low
$19.34
Volume
205,094
Avg. Vol
182,424
52-wk High
$36.12
52-wk Low
$16.97

About

Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other food allergies. The Company's therapeutic approach, which it refers to as Characterized Oral Desensitization Immunotherapy (CODIT), is... (more)

Overall

Beta: --
Market Cap(Mil.): $1,281.57
Shares Outstanding(Mil.): 50.54
Dividend: --
Yield (%): --

Financials

  AIMT.OQ Industry Sector
P/E (TTM): -- 69.38 32.67
EPS (TTM): -2.24 -- --
ROI: -50.47 8.95 14.48
ROE: -50.82 10.09 15.78
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates